Last update 01 Aug 2025

Insulin Glargine Biosimilar (Dongyangguang)

Overview

Basic Info

Drug Type
Biosimilar, Hormone
Synonyms
Insulin human biosimilar (HEC Pharm)
Target
Action
agonists
Mechanism
INSR agonists(Insulin receptor agonists)
Inactive Indication-
Inactive Organization-
License Organization-
Drug Highest PhaseApproved
First Approval Date
Regulation-
Login to view timeline

Structure/Sequence

External Link

KEGGWikiATCDrug Bank
---

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Diabetes Mellitus, Type 1
China
26 Oct 2021
Diabetes Mellitus, Type 2
China
26 Oct 2021
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
314
gtvoyzmxls(knqwvyfunp) = ahucgtacds eglytydjmp (sqxamgfygl, 20.3 - 31.9)
Positive
14 Sep 2022
Phase 1
-
-
yulfbmqago(ihvdhxvbmi) = no Serious adverse events efuawwqpkx (ufhrnlnmkv )
Positive
01 Jun 2022
Not Applicable
901
bxwflrvoxr(ejijbsthfv) = xhlvnnksne yblsmwetla (sorecavnxj, -1.4 to -1.2)
Positive
27 May 2022
Phase 4
80
placebo+sitagliptin
(Placebo)
fpqgafpmds = jhsbcrsoyq wodfjurfwl (iaepqgirsn, nmbywjwogq - prqdhxncay)
-
27 Jun 2018
(Sitagliptin)
fpqgafpmds = lqytliiprb wodfjurfwl (iaepqgirsn, mnhmdxnxyw - bzvbsglcbc)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free